What is he best known for?
The fields of study he is best known for:
Molecular biology, Genetics, Biochemistry, Gene and Cell culture are his primary areas of study.
His research in Molecular biology intersects with topics in Mutation, Receptor, Ectodomain and Cytoplasm.
His study explores the link between Cell culture and topics such as Myeloid that cross with problems in In vitro, Antibody-dependent cell-mediated cytotoxicity, Bone marrow, Interleukin and CD19.
His In vitro research integrates issues from Leukemia and Antigen.
His study looks at the relationship between Leukemia and fields such as Tumor necrosis factor alpha, as well as how they intersect with chemical problems.
Georg H. Fey has researched Antibody in several fields, including Programmed cell death and Virology.
His most cited work include:
- T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice (495 citations)
- Human complement component C3: cDNA coding sequence and derived primary structure (338 citations)
- Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor. (181 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Molecular biology, Antigen, Antibody, Cancer research and CD19.
His Molecular biology study combines topics in areas such as Cell culture, Gene, Recombinant DNA, Antibody-dependent cell-mediated cytotoxicity and Immunotoxin.
His Antibody-dependent cell-mediated cytotoxicity research includes elements of Immunoglobulin G and Avidity.
His study in Antigen is interdisciplinary in nature, drawing from both Phage display, Stem cell and Minimal residual disease.
The study incorporates disciplines such as Virology, Natural killer cell, Cytolysis, Pseudomonas exotoxin and Lysis in addition to Antibody.
His work carried out in the field of Cancer research brings together such families of science as Apoptosis, Leukemia, Immunology and Immunotherapy.
He most often published in these fields:
- Molecular biology (55.56%)
- Antigen (33.33%)
- Antibody (30.30%)
What were the highlights of his more recent work (between 2013-2018)?
- Cancer research (29.29%)
- Immunotherapy (18.18%)
- Antigen (33.33%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cancer research, Immunotherapy, Antigen, Antibody and Immunology.
His Cancer research research is multidisciplinary, relying on both T cell, Dual targeting and Cancer immunotherapy.
His Immunotherapy research includes themes of Molecular biology and Immunotoxin.
Georg H. Fey has included themes like Antibody-dependent cell-mediated cytotoxicity, Fusion protein, Cytolysis, Cell cycle and Cell biology in his Molecular biology study.
Georg H. Fey usually deals with Antigen and limits it to topics linked to Myeloid leukemia and Adoptive cell transfer, CD135, Stem cell and Chimeric antigen receptor.
As a part of the same scientific study, he usually deals with the Antibody, concentrating on Lysis and frequently concerns with Cancer cell.
Between 2013 and 2018, his most popular works were:
- Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia (71 citations)
- Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone. (24 citations)
- A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein. (20 citations)
In his most recent research, the most cited papers focused on:
His primary scientific interests are in Molecular biology, Immunotherapy, Antibody, Antigen and Chimeric antigen receptor.
The various areas that Georg H. Fey examines in his Molecular biology study include Cell, Cytokine and HLA-DR Antigen.
The concepts of his Immunotherapy study are interwoven with issues in Cell cycle, Immunotoxin and Fusion protein.
His Antibody research entails a greater understanding of Immunology.
His work in the fields of CD19 overlaps with other areas such as CD16.
His Chimeric antigen receptor research incorporates elements of CD28, Transfection, RNA transfection and Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
